rs1561595610

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_138773.4(SLC25A46):​c.26T>A​(p.Phe9Tyr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

SLC25A46
NM_138773.4 missense

Scores

2
13
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.57
Variant links:
Genes affected
SLC25A46 (HGNC:25198): (solute carrier family 25 member 46) This gene encodes a mitochondrial solute carrier protein family member. It functions in promoting mitochondrial fission, and prevents the formation of hyperfilamentous mitochondria. Mutation of this gene results in neuropathy and optic atrophy. [provided by RefSeq, Aug 2016]
TMEM232 (HGNC:37270): (transmembrane protein 232) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A46NM_138773.4 linkc.26T>A p.Phe9Tyr missense_variant Exon 1 of 8 ENST00000355943.8 NP_620128.1 Q96AG3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A46ENST00000355943.8 linkc.26T>A p.Phe9Tyr missense_variant Exon 1 of 8 1 NM_138773.4 ENSP00000348211.3 Q96AG3-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 29, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.26T>A (p.F9Y) alteration is located in exon 1 (coding exon 1) of the SLC25A46 gene. This alteration results from a T to A substitution at nucleotide position 26, causing the phenylalanine (F) at amino acid position 9 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.56
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
28
DANN
Uncertain
0.99
DEOGEN2
Benign
0.015
T;.
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.80
T;T
M_CAP
Pathogenic
0.61
D
MetaRNN
Uncertain
0.59
D;D
MetaSVM
Uncertain
0.30
D
MutationAssessor
Uncertain
2.4
M;M
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-0.64
N;N
REVEL
Uncertain
0.49
Sift
Uncertain
0.020
D;D
Sift4G
Uncertain
0.041
D;D
Polyphen
0.40
B;.
Vest4
0.61
MutPred
0.34
Gain of phosphorylation at F9 (P = 0.012);Gain of phosphorylation at F9 (P = 0.012);
MVP
0.58
MPC
0.34
ClinPred
0.98
D
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Varity_R
0.61
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-110074846; API